Ocular Therapeutix
OCUL
OCUL
68 hedge funds and large institutions have $99.9M invested in Ocular Therapeutix in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
–
Holders Change %
0%
% of All Funds
1.48%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
13
Increased
24
Reduced
15
Closed
11
Calls
$1.23M
Puts
$647K
Net Calls
+$584K
Net Calls Change
+$25K
Top Buyers
1 |
OM
Opaleye Management
Boston,
Massachusetts
|
$13M |
2 |
DAM
Deltec Asset Management
New York
|
$6.23M |
3 |
Man Group
London,
United Kingdom
|
$9.5M |
4 |
![]()
JPMorgan Chase & Co
New York
|
$1.3M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
$8.24M |